Kathryn Hobbs
- Rheumatology top 2%
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Molecular Biology
- Physiology
- Co-authors
- Larry BorishJulie NegriMary D. KlinnertLanny J. RosenwasserMark LebwohlScott E. PlevyDavid E. YocumMarc C. Hochberg
- Topics
- Systemic Lupus Erythematosus Research (8 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)Rheumatoid Arthritis Research and Therapies (4 papers)
- Journals
- Journal of Biological ChemistryAmerican Journal of Respiratory and Critical Care MedicineGenetics
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Kathryn Hobbs
24 papers receiving 960 citations
Peers
Comparison fields: 5 of 88
- Rheumatology 434
- Immunology 424
- Radiology, Nuclear Medicine and Imaging 246
- Molecular Biology 209
- Physiology 144
Countries citing papers authored by Kathryn Hobbs
This map shows the geographic impact of Kathryn Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Hobbs more than expected).
Fields of papers citing papers by Kathryn Hobbs
This network shows the impact of papers produced by Kathryn Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Hobbs. The network helps show where Kathryn Hobbs may publish in the future.
Co-authorship network of co-authors of Kathryn Hobbs
This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Hobbs. A scholar is included among the top collaborators of Kathryn Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Hobbs. Kathryn Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 169 | |
| 7 | 14 | |
| 8 | 33 | |
| 9 | 97 | |
| 10 | 50 | |
| 11 | 40 | |
| 12 | 1 | |
| 13 | Epratuzumab (anti-CD22 mAb targeting b-cells) provides clinically meaningful reductions in corticosteroid (CS) use with a favorable safety profile in patients with Moderate/Severe flaring SLE: Results from Randomized controlled trials (RCTs) | 22 |
| 14 | 7 | |
| 15 | 161 | |
| 16 | 25 | |
| 17 | 42 | |
| 18 | 213 | |
| 19 | 4 | |
| 20 | 6 |
About Kathryn Hobbs
Kathryn Hobbs is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 988 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (8 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). The work is most often cited by research in Rheumatology (434 citations), Immunology (424 citations) and Radiology, Nuclear Medicine and Imaging (246 citations). Kathryn Hobbs has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Larry Borish, Julie Negri, Mary D. Klinnert, Lanny J. Rosenwasser, Mark Lebwohl, Scott E. Plevy, David E. Yocum, Marc C. Hochberg, Kenneth Kalunian and Caroline Gordon. Their work appears in journals such as Journal of Biological Chemistry, American Journal of Respiratory and Critical Care Medicine and Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.